A Controlled Trial of Polyglytone 6211 versus Poliglecaprone 25 for Use in Intradermal Suturing in Dogs

The objective of this work was the comparative evaluation of the healing process after employing 4/0 poliglecaprone 25 and 4/0 polyglytone 6211 in a continuous intradermal suture pattern. Ten Beagle dogs were used, in which skin incisions were created surgically and subsequently were sutured by mean...

Full description

Bibliographic Details
Main Authors: Pagona Gouletsou, Nikitas Prassinos, Lysimachos Papazoglou, Polychronis Kostoulas, Apostolos Galatos
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Animals
Subjects:
Online Access:https://www.mdpi.com/2076-2615/11/11/3094
_version_ 1797410926569193472
author Pagona Gouletsou
Nikitas Prassinos
Lysimachos Papazoglou
Polychronis Kostoulas
Apostolos Galatos
author_facet Pagona Gouletsou
Nikitas Prassinos
Lysimachos Papazoglou
Polychronis Kostoulas
Apostolos Galatos
author_sort Pagona Gouletsou
collection DOAJ
description The objective of this work was the comparative evaluation of the healing process after employing 4/0 poliglecaprone 25 and 4/0 polyglytone 6211 in a continuous intradermal suture pattern. Ten Beagle dogs were used, in which skin incisions were created surgically and subsequently were sutured by means of continuous intradermal pattern using polyglytone 6211 or poliglecaprone 25 suture. Cosmetic, clinical, and histologic scores were evaluated. The cosmetic appearance of the wounds was blindly evaluated on days 7, 14, 28, 180, 360, 730, and 1095. On the same days, tissue biopsy was performed for histological evaluation. Clinical evaluation was performed initially daily, then weekly, monthly, and finally yearly, till day 1095. The clinical appearance of the intradermal pattern with both sutures was initially very good, deteriorated in the second post-operative month and thereafter improved. The cosmetic, clinical, and histological differences between the two suture materials were minimal and statistically insignificant. Polyglytone 6211 is sufficient for use in intradermal suturing in dogs. However, its earlier absorption compared to poliglecaprone 25 did not have any beneficial effect on cutaneous wound healing and scar appearance in the experimental animals.
first_indexed 2024-03-09T04:37:30Z
format Article
id doaj.art-eaa809ca75434b0e890bd82c0c71b76a
institution Directory Open Access Journal
issn 2076-2615
language English
last_indexed 2024-03-09T04:37:30Z
publishDate 2021-10-01
publisher MDPI AG
record_format Article
series Animals
spelling doaj.art-eaa809ca75434b0e890bd82c0c71b76a2023-12-03T13:27:28ZengMDPI AGAnimals2076-26152021-10-011111309410.3390/ani11113094A Controlled Trial of Polyglytone 6211 versus Poliglecaprone 25 for Use in Intradermal Suturing in DogsPagona Gouletsou0Nikitas Prassinos1Lysimachos Papazoglou2Polychronis Kostoulas3Apostolos Galatos4Clinic of Obstetrics and Reproduction, Faculty of Veterinary Science, School of Health Sciences, University of Thessaly, Trikalon 224, 43100 Karditsa, GreeceCompanion Animal Clinic, School of Veterinary Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, S Boutyra 11, 54627 Thessaloniki, GreeceCompanion Animal Clinic, School of Veterinary Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, S Boutyra 11, 54627 Thessaloniki, GreeceLaboratory of Epidemiology, Faculty of Public Health, School of Health Sciences, University of Thessaly, Terma Mavromichali, 43131 Karditsa, GreeceClinic of Surgery, Faculty of Veterinary Science, School of Health Sciences, University of Thessaly, Trikalon 224, 43100 Karditsa, GreeceThe objective of this work was the comparative evaluation of the healing process after employing 4/0 poliglecaprone 25 and 4/0 polyglytone 6211 in a continuous intradermal suture pattern. Ten Beagle dogs were used, in which skin incisions were created surgically and subsequently were sutured by means of continuous intradermal pattern using polyglytone 6211 or poliglecaprone 25 suture. Cosmetic, clinical, and histologic scores were evaluated. The cosmetic appearance of the wounds was blindly evaluated on days 7, 14, 28, 180, 360, 730, and 1095. On the same days, tissue biopsy was performed for histological evaluation. Clinical evaluation was performed initially daily, then weekly, monthly, and finally yearly, till day 1095. The clinical appearance of the intradermal pattern with both sutures was initially very good, deteriorated in the second post-operative month and thereafter improved. The cosmetic, clinical, and histological differences between the two suture materials were minimal and statistically insignificant. Polyglytone 6211 is sufficient for use in intradermal suturing in dogs. However, its earlier absorption compared to poliglecaprone 25 did not have any beneficial effect on cutaneous wound healing and scar appearance in the experimental animals.https://www.mdpi.com/2076-2615/11/11/3094caninepolyglytone 6211poliglecaprone 25intradermalwound healing
spellingShingle Pagona Gouletsou
Nikitas Prassinos
Lysimachos Papazoglou
Polychronis Kostoulas
Apostolos Galatos
A Controlled Trial of Polyglytone 6211 versus Poliglecaprone 25 for Use in Intradermal Suturing in Dogs
Animals
canine
polyglytone 6211
poliglecaprone 25
intradermal
wound healing
title A Controlled Trial of Polyglytone 6211 versus Poliglecaprone 25 for Use in Intradermal Suturing in Dogs
title_full A Controlled Trial of Polyglytone 6211 versus Poliglecaprone 25 for Use in Intradermal Suturing in Dogs
title_fullStr A Controlled Trial of Polyglytone 6211 versus Poliglecaprone 25 for Use in Intradermal Suturing in Dogs
title_full_unstemmed A Controlled Trial of Polyglytone 6211 versus Poliglecaprone 25 for Use in Intradermal Suturing in Dogs
title_short A Controlled Trial of Polyglytone 6211 versus Poliglecaprone 25 for Use in Intradermal Suturing in Dogs
title_sort controlled trial of polyglytone 6211 versus poliglecaprone 25 for use in intradermal suturing in dogs
topic canine
polyglytone 6211
poliglecaprone 25
intradermal
wound healing
url https://www.mdpi.com/2076-2615/11/11/3094
work_keys_str_mv AT pagonagouletsou acontrolledtrialofpolyglytone6211versuspoliglecaprone25foruseinintradermalsuturingindogs
AT nikitasprassinos acontrolledtrialofpolyglytone6211versuspoliglecaprone25foruseinintradermalsuturingindogs
AT lysimachospapazoglou acontrolledtrialofpolyglytone6211versuspoliglecaprone25foruseinintradermalsuturingindogs
AT polychroniskostoulas acontrolledtrialofpolyglytone6211versuspoliglecaprone25foruseinintradermalsuturingindogs
AT apostolosgalatos acontrolledtrialofpolyglytone6211versuspoliglecaprone25foruseinintradermalsuturingindogs
AT pagonagouletsou controlledtrialofpolyglytone6211versuspoliglecaprone25foruseinintradermalsuturingindogs
AT nikitasprassinos controlledtrialofpolyglytone6211versuspoliglecaprone25foruseinintradermalsuturingindogs
AT lysimachospapazoglou controlledtrialofpolyglytone6211versuspoliglecaprone25foruseinintradermalsuturingindogs
AT polychroniskostoulas controlledtrialofpolyglytone6211versuspoliglecaprone25foruseinintradermalsuturingindogs
AT apostolosgalatos controlledtrialofpolyglytone6211versuspoliglecaprone25foruseinintradermalsuturingindogs